2 domains / 4 areas / 3 specializations
CTC Clinical Trial Consultants AB
Data updated
Full-service CRO with in-house research units in Sweden and the Netherlands. Psychedelic-specific evidence remains weaker than its general CNS and early-phase site-network capability.
Clinical Trial Infrastructure Snapshot
CROs & Full-Service Trial DeliveryService Model
Full-Service CRO
Service Coverage
2 countries
Psychedelic Experience
Claimed Psychedelic Trial Experience
Last Source Check
Jun 18, 2026
Public Sources
3
Lifecycle Coverage
Service Coverage Countries
Phase Coverage
Capabilities
Research Update
Public-source profile available
Last checked Jun 18, 2026 across 3 sources.
Search Finding
Strong CRO/site-network evidence; psychedelic-specific signal remains weaker and needs stronger primary confirmation.
Source Caution
General CRO/site-network capability is clear, but the psychedelic-specific role needs stronger primary-source confirmation.
Service Notes
Keep CTC in CTI because the CRO and in-house site network fit the bucket, but treat psychedelic relevance as needs-review until sponsor or registry evidence is stronger.
Linked Stakeholders
No linked stakeholders yet.
Quick Facts
- Type
- Other
- HQ
- Uppsala office - Dag Hammarskjolds vag 10B, 752 37 Uppsala, Sweden
- Website
- Visit